Sun Pharma has full faith that Gandhi conducts himself with the utmost integrity in any situation, i

Quote




anonymous said:
The not-so-funny thing is that the first time I had a sit down meeting with AG, he told me things that had me thinking ‘this guy is sketch at best’.
Insider trading is just ONE thing, but I assure you, OIG has him sleeping, dressed, with one eye open and passport in hand.
Click to expand...
OIG ‘may’ be poking around again.
RG can sink the sub.
 








anonymous said:
That’s exactly why he’s been NSM for like 8 years ?
“Keep your friends close and your enemies (whistleblowers) closer”
-AG
Click to expand...
A sample diversion issue at OPH was swept under the rug. The person who attempted to
divert samples gave her 2 weeks and quit with no repercussions , the person who reported the violation was terminated and given a severance offer.
 




anonymous said:
A sample diversion issue at OPH was swept under the rug. The person who attempted to
divert samples gave her 2 weeks and quit with no repercussions , the person who reported the violation was terminated and given a severance offer.
Click to expand...
Sun and Abhay have little-to-no moral, legal or ethical compass. It’s all about the rupee. I can’t believe he’s still around - what a joke.
 




anonymous said:
A sample diversion issue at OPH was swept under the rug. The person who attempted to
divert samples gave her 2 weeks and quit with no repercussions , the person who reported the violation was terminated and given a severance offer.
Click to expand...
It’s interesting that at least one person who could totally blow the whistle on sun is still there. He must have enough evidence that they know they have to keep him.
 




anomous said:
  • Apr 11, 2019,
  • Updated Apr 11, 2019, 8:53 PM IST
(Eds: Adding Sun Pharma statement after para 14) New Delhi, Apr 11 (PTI) Sun Pharma group's senior executive Abhay Arvind Gandhi and his wife Kiran have settled with Sebi a case related to insider trading in shares of Ranbaxy Laboratories in 2014.Both have paid a total of over Rs 70 lakh as settlement charges. At the time of alleged violation, Abhay Arvind Gandhi was the CEO of Sun Pharma Laboratories Ltd (SPLL), a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd.Currently, Abhay Gandhi is CEO of Sun Pharma's North America business. Gandhi and his wife traded in Ranbaxy shares soon after Japanese major Daiichi, in 2014, agreed to sell Ranbaxy to Sun Pharma.According to separate notices sent to the two individuals, they had traded in the shares of Ranbaxy when the proposed deal was to be made public. The proposed deal was UPSI (Unpublished Price Sensitive Information) from February 14, 2014 to April 6, 2014. By trading in the shares of Ranbaxy during the UPSI period, both allegedly violated prohibition of insider trading norms, as per the notices. As Gandhi was then the chief of SPLL, he and his wife were insiders under the Sebi norms. Gandhi and Kiran traded in 454 shares and 6,770 shares, respectively, during the UPSI period. In two separate but similarly-worded orders issued on Thursday, Sebi said the two individuals sought to settle the adjudication proceedings initiated against them in 2017.Under Sebi's settlement mechanism, without admission or denial of guilt, both proposed to pay Rs 35.06 lakh each to settle the case.The settlement amounts proposed were approved by a panel of Sebi's Whole Time Members, according to the two orders.While settling the case, the regulator also said that enforcement actions could be initiated if any representation made by the two individuals is found to be untrue. "Sun Pharma is pleased that the matter of Mr Abhay Gandhi and his spouse has been brought to a closure. "Without admitting or denying the findings of fact and conclusions of law, Mr Gandhi and his spouse have proposed to settle the proceedings with Sebi," the company said in a statement. Sun Pharma has full faith that Gandhi conducts himself with the utmost integrity in any situation, it added. PTI VHP AA RAM PTI VHP RAM
Click to expand...
 
















Top Bottom
Back
Quote